LEARN MORE ABOUT THE MEMBERS OF THE ONCOVALUE CONSORTIUM

The ONCOVALUE Consortium

The ONCOVALUE consortium aims to unlock the full potential of Real World Data (RWD) and Real World Evidence (RWE) to maintain the affordability and sustainability of the healthcare system or the treatment of cancer. Below you will find an overview of members of The ONCOVALUE Consortium.

HUS

Netherlands Cancer Institute

Rigshospitalet

IPO Porto

IRST

Rijnstate

IQVIA

BC Platforms

Siemens Healthineers

Elevate

PNO Innovation (CiaoTech)

PNO Innovation (TTOPSTART)

Grant Agreement 101095245

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Commission. Neither the European Union nor the granting authority can be held responsible for them.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license – Privacy Policy & Cookies – TERMS AND CONDITIONS